Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description EU Business Development Director – GMP Labs – Analytical Services Division You will lead our European Business Development strategy within our GMP lab services business with responsibility to drive